Increased atherosclerotic lesions and Th17 in interleukin-18 deficient apolipoprotein E-knockout mice fed high-fat diet

Molecular Immunology

Volumn 47, Issue 1, 2009, Pages 37-45

  Pejnovic, Nada ^a   Vratimos, Athanassios ^a   Lee, Sang Hee ^a   Popadic, Dusan ^a   Takeda, Kiyoshi ^b   Akira, Shizuo ^c   Chan, Woon Ling ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b KYUSHU UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Cholesterol; IL 23; Inflammation; Th17

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; GAMMA INTERFERON; HOMOCYSTEINE; INTERLEUKIN 18; INTERLEUKIN 23; PROSTAGLANDIN E2; TRIACYLGLYCEROL;

AORTA OCCLUSION; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CYTOKINE PRODUCTION; FAT INTAKE; HYPERCHOLESTEROLEMIA; IMMUNOSTIMULATION; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN DEFICIENCY; REVIEW; SMOOTH MUSCLE FIBER; TH1 CELL; TH17 CELL; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CHOLESTEROL; DIETARY FATS; HOMOCYSTEINE; INTERLEUKIN-17; INTERLEUKIN-18; INTERLEUKIN-23; MICE; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; T-LYMPHOCYTES, HELPER-INDUCER;

MUS; RATTUS;

EID: 70350374339     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2008.12.032     Document Type: Review

References (40)

1. Aggarwal S., Ghilardi N., Xie M.H., de Sauvage F.J., and Gurney A.L. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 278 (2003) 1910-1914
2. Bettelli E., Oukka M., and Kuchroo V.K. T(H)-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 8 (2007) 345-350
3. Binder C.J., Chang M.K., Shaw P.X., Miller Y.I., Hartvigsen K., Dewan A., and Witztum J.L. Innate and acquired immunity in atherogenesis. Nat. Med. 8 (2002) 1218-1226
4. Calara F., Silvestre M., Casanada F., Yuan N., Napoli C., and Palinski W. Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient mice. J. Pathol. 195 (2001) 257-263
5. Chan W.L., Pejnovic N., Hamilton H., Liew T.V., Popadic D., Poggi A., and Khan S.M. Atherosclerotic abdominal aortic aneurysm and the interaction between autologous human plaque-derived vascular smooth muscle cells, type 1 NKT, and helper T cells. Circ. Res. 96 (2005) 675-683
6. Doronzo G., Russo I., Mattiello L., Trovati M., and Anfossi G. Homocysteine rapidly increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells. Role of phosphatidyl inositol 3-kinase and mitogen activated protein kinase pathways. Thromb. Haemost. 94 (2005) 1285-1293
7. Elhage R., Jawien J., Rudling M., Ljunggren H.G., Takeda K., Akira S., Bayard F., and Hansson G.K. Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice. Cardiovasc. Res. 59 (2003) 234-240
8. Fan J., and Watanabe T. Inflammatory reactions in the pathogenesis of atherosclerosis. J. Atheroscler. Thromb. 10 (2003) 63-71
9. Gangemi S., Basile G., Merendino R.A., Minciullo P.L., Novick D., Rubinstein M., Dinarello C.A., Lo Balbo C., Franceschi C., Basili S., D'Urbano E., Davi G., Nicita-Mauro V., and Romano M. Increased circulating Interleukin-18 levels in centenarians with no signs of vascular disease: another paradox of longevity?. Exp. Gerontol. 38 (2003) 669-672
10. Getz G.S. Mouse model of unstable atherosclerotic plaque?. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 2503-2505
11. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., and Weaver C.T. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6 (2005) 1123-1132
12. Jackson C.L., Bennett M.R., Biessen E.A., Johnson J.L., and Krams R. Assessment of unstable atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 27 (2007) 714-720
13. Johnson J.L., and Jackson C.L. Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse. Atherosclerosis 154 (2001) 399-406
14. King V.L., Szilvassy S.J., and Daugherty A. Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor-/- mice. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 456-461
15. Koenig W., Khuseyinova N., Baumert J., Thorand B., Loewel H., Chambless L., Meisinger C., Schneider A., Martin S., Kolb H., and Herder C. Increased concentrations of C-reactive protein and IL-6 but not IL-18 are independently associated with incident coronary events in middle-aged men and women: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 2745-2751
16. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., McClanahan T., Kastelein R.A., and Cua D.J. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201 (2005) 233-240
17. Lin S.J., Yen H.T., Chen Y.H., Ku H.H., Lin F.Y., and Chen Y.L. Expression of interleukin-1 beta and interleukin-1 receptor antagonist in oxLDL-treated human aortic smooth muscle cells and in the neointima of cholesterol-fed endothelia-denuded rabbits. J. Cell. Biochem. 88 (2003) 836-847
18. Malek A.M., Alper S.L., and Izumo S. Hemodynamic shear stress and its role in atherosclerosis. JAMA 282 (1999) 2035-2042
19. Mallat Z., Corbaz A., Scoazec A., Graber P., Alouani S., Esposito B., Humbert Y., Chvatchko Y., and Tedgui A. Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability. Circ. Res. 89 (2001) E41-E45
20. Nakashima Y., Plump A.S., Raines E.W., Breslow J.L., and Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. 14 (1994) 133-140
21. Netea M.G., Joosten L.A., Lewis E., Jensen D.R., Voshol P.J., Kullberg B.J., Tack C.J., van Krieken H., Kim S.H., Stalenhoef A.F., van de Loo F.A., Verschueren I., Pulawa L., Akira S., Eckel R.H., Dinarello C.A., van den Berg W., and van der Meer J.W. Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nat. Med. 12 (2006) 650-656
22. Novick D., Kim S.H., Fantuzzi G., Reznikov L.L., Dinarello C.A., and Rubinstein M. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 10 (1999) 127-136
23. Okamura H., Tsutsi H., Komatsu T., Yutsudo M., Hakura A., Tanimoto T., Torigoe K., Okura T., Nukada Y., Hattori K., et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378 (1995) 88-91 (see comments)
24. Paris D., Town T., Humphrey J., Yokota K., and Mullan M. Cholesterol modulates vascular reactivity to endothelin-1 by stimulating a pro-inflammatory pathway. Biochem. Biophys. Res. Commun. 274 (2000) 553-558
25. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., Wang Y., Hood L., Zhu Z., Tian Q., and Dong C. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6 (2005) 1133-1141
26. Paulukat J., Bosmann M., Nold M., Garkisch S., Kampfer H., Frank S., Raedle J., Zeuzem S., Pfeilschifter J., and Muhl H. Expression and release of IL-18 binding protein in response to IFN-gamma. J. Immunol. 167 (2001) 7038-7043
27. Piedrahita J.A., Zhang S.H., Hagaman J.R., Oliver P.M., and Maeda N. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc. Natl. Acad. Sci. USA 89 (1992) 4471-4475
28. Plump A.S., Smith J.D., Hayek T., Aalto-Setala K., Walsh A., Verstuyft J.G., Rubin E.M., and Breslow J.L. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71 (1992) 343-353
29. Reardon C.A., Blachowicz L., White T., Cabana V., Wang Y., Lukens J., Bluestone J., and Getz G.S. Effect of immune deficiency on lipoproteins and atherosclerosis in male apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 1011-1016
30. Reznikov L.L., Kim S.H., Westcott J.Y., Frishman J., Fantuzzi G., Novick D., Rubinstein M., and Dinarello C.A. IL-18 binding protein increases spontaneous and IL-1-induced prostaglandin production via inhibition of IFN-gamma. Proc. Natl. Acad. Sci. USA 97 (2000) 2174-2179
31. Rosenfeld M.E., Polinsky P., Virmani R., Kauser K., Rubanyi G., and Schwartz S.M. Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 2587-2592
32. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340 (1999) 115-126 (see comments)
33. Sheibanie A.F., Tadmori I., Jing H., Vassiliou E., and Ganea D. Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells. FASEB J. 18 (2004) 1318-1320
34. Takeda K., Tsutsui H., Yoshimoto T., Adachi O., Yoshida N., Kishimoto T., Okamura H., Nakanishi K., and Akira S. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8 (1998) 383-390
35. Tellides G., Tereb D.A., Kirkiles-Smith N.C., Kim R.W., Wilson J.H., Schechner J.S., Lorber M.I., and Pober J.S. Interferon-gamma elicits arteriosclerosis in the absence of leukocytes. Nature 403 (2000) 207-211
36. VanderLaan P.A., Reardon C.A., and Getz G.S. Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arterioscler. Thromb. Vasc. Biol. 24 (2004) 12-22
37. Whitman S.C., Ravisankar P., and Daugherty A. Interleukin-18 enhances atherosclerosis in apolipoprotein E(-/-) mice through release of interferon-gamma. Circ. Res. 90 (2002) E34-E38
38. Wiekowski M.T., Leach M.W., Evans E.W., Sullivan L., Chen S.C., Vassileva G., Bazan J.F., Gorman D.M., Kastelein R.A., Narula S., and Lira S.A. Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death. J. Immunol. 166 (2001) 7563-7570
39. Williams H., Johnson J.L., Carson K.G., and Jackson C.L. Characteristics of intact and ruptured atherosclerotic plaques in brachiocephalic arteries of apolipoprotein E knockout mice. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 788-792
40. Zhang S.H., Reddick R.L., Piedrahita J.A., and Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258 (1992) 468-471